Skip to content

Effect of Panchakarma (Vamana) and Varadi Ghanavati in Prameha (Diabetes mellitus)

Controlled Evaluation of the Composite Management of Prameha with Samshodhana and Varadi Ghanavati.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/010127
Enrollment
45
Registered
2017-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Panchakarma (Vamana) treatment followed by Varadi Ghanavati: Panchakarma (Vamana) treatment conducted once, which is followed by Varadi Ghanavati 500 mg in dose of one tablet thrice dai

Sponsors

The Dean R A Podar Medical College Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients showing classical symptoms of Prameha, who are either a known diabetic for less than a year or a newly diagnosed diabetic. 2. Fasting blood sugar below 250 mg/dl and post prandial blood sugar below 500 mg/dl. 3. Fit for Vamana treatment

Exclusion criteria

Exclusion criteria: 1. Fasting blood sugar above 250 mg% and post prandial blood sugar above 500mg%. 2. IDDM and those who are under insulin therapy. 3. Acute or chronic complications of Diabetes mellitus 4. Suffering from other diseases such as Tuberculosis, cardiac diseases. 5. Unfit for Vamana

Design outcomes

Primary

MeasureTime frame
Effect on symptoms of Prameha according to four point scale at the interval of 2 weeks till 12 weeks. Effect on Blood sugar - fasting and post prandial at the interval of 2 weeks till 12 weeks. Effect on glycosylated haemoglobin (HbA1c) at base line and 12 weeks.Timepoint: Effect on symptoms of Prameha according to four point scale. Effect on Blood sugar - fasting and post prandial, glycosylated haemoglobin

Secondary

MeasureTime frame
Effect on lipid profile, Haemogram, Renal profile, Hepatic Profile at the base line and at 12 weeks. Effect on weight and body mass index (BMI) at the interval of 2 weeks till 12 weeksTimepoint: At base line and 12 weeks. At the interval of 2 weeks till 12 weeks.

Countries

India

Contacts

Public ContactDr Shashikant S Sakapal

R A Podar Medical College (Ayu)

drsssakapal@rediffmail.com9892439562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026